Patent applications published 17 August 2011
Selected patent applications from the weekly European Patents Bulletin
- Compsns and methods for treating endothelial disorders
Arginetix; Johns Hopkins University 2355657*
- Novel lipids and compsns for the delivery of therapeutics
Alnylam Pharmaceuticals 2355658*
- Fused heterocyclic M1 receptor positive allosteric modulators
Merck Sharp & Dohme 235659*
- Compsns and methods for treating multiple sclerosis
Biovista 2355660*
- Solution of lipophilic substances, especially medicinal solutions
Universität Regensburg 2355794*
- Biodegradable alpha-2 adrenergic agonist polymeric implants
Allergan 2355795*
- Salicylic acid compsn
Quinnova Pharmaceuticals 2355796*
- Compsn for targeting dendritic cells
Domantis 2355797*
- Modified cationic liposome adjuvans
Statens Serum Institut 2355798*
- Releasable fusogenic lipids for nucleic acid delivery systems
Enzon Pharmaceuticals 2355799*
- Nano-particles of beta-lactam derivatives
Centre National de la Recherche Scientifique 2355800*
- Statin nanoparticles
Centre National de la Recherche Scientifique; Université Paris Sud 2355801*
- Intermediate and oral administrative formats containing lenalidomide
Ratiopharm 2355802*
- Organogel compsns and processes for producing
Archer-Daniels-Midland 2355803*
- Quetiapine compsn
KRKA 2355804*
- Rifaximin complexes
Cipla 2355805*
- Non-aqueous colloidal formulation
Profimed 2355806*
- Inhibitors of dimethylarginine dimethylaminohydrolase
Christian-Albrechts-Universität zu Kiel 2355807*
- Arformoterol and tiotropium compsns and methods for use
Sunovion Pharmaceuticals 2355808*
- Methods for preventing or reducing colon carcinogenesis
Giuliani International 2355809*
- Methods for preventing or reducing carcinogenesis or oxidative stress
Giuliani International 2355810*
- Therapeutic compsns
Provexis Natural Products 2355811*
- A method of lowering circulating oxidised low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
Framroze, Bomi 2355812*
- Pyrones for the treatment of metabolic disorders
Limerick BioPharma 2355814*
- Use of leukotriene inhibitors for treating lung diseases in prematurely born infants
Rupprecht, Sabine 2355815*
- Novel uses
Destiny Pharma 2355816*
- Heterocyclic gamma secretase modulators
F Hoffmann-La Roche 2355817*
- Methods and compsns for treating status epilepticus and seizures causing status epilepticus
The United States of America, as represented by The Secretary of the Army, on behalf of the Walter Reed Army Institute of Research 2355818*
- Treating cancer by modulating a MNK
Novartis; University Hospital Basel 2355819*
- P70 S6 kinase inhibitor and motor inhibitor combination therapy
Eli Lilly 2355820*
- P70 S6 kinase inhibitor and EGFR inhibitor combination therapy
Eli Lilly 2355821*
- Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo(B)thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
Envivo Pharmaceuticals 2355822*
- Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
Boehringer Ingelheim International 2355823*
- Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
Iroko Cardio 2355824*
- Compounds for the treatment of inflammatory disorders
Schering 2355825*
- Compounds and methods of promoting oligodendrocyte precursor differentiation
The Cleveland Clinic Foundation 2355826*
- Methods of treating thalassemia
TargeGen 2355827*
- Therapies for haematologic malignancies
Calistoga Pharmaceuticals 2355828*
- Combination of insulin with triazine derivatives and its use for treating diabetes
Merck Patent 2355829*
- Compsns comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions
Adams, Kenneth 2355830*
- Use of INKT or TLR agonists for protecting against or treating a disease such as acute infection or cancer
Ludwig Institute for Cancer Research 2355831*
- Compsns and methods for treating retrovirus infections
Centre National de la Recherche Scientifique 2355832*
- FAS/FASL or other death receptor targeted methods and compsns for killing tumour cells
Promising Future 2355833*
-
Patent applications published 24 August 2011
Hydroxyethylamino sulphonamide derivatives
Concert Pharmaceuticals 2358198*
- Improving cancer therapy by docetaxel and granulocyte colony-stimulating factor (G-SCF)
Optimata 2358199*
- Substituted bicyclic amines for the treatment of diabetes
Merck Sharp & Dohme 2358200*
- Benzimidazole and aza-benzimidazole carboxamides
Merck Sharp & Dohme 2358202*
- Platinum acridine anti-cancer compounds and methods thereof
Wake Forest University 2358203*
- Organic compounds
Intra-cellular Therapies 2358204*
- Peptides that bind to silica-coated particles
EI du Pont de Nemours 2358348*
- Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
Allergan 2358349*
- Aerosol formulation for the inhalation of beta agonists
Boehringer Ingelheim International 2358350*
- Drug delivery system
Bayer Pharma 2358351*
- Compsns and methods for promoting bone formation
Warsaw Orthopaedic 2358352*
- Aerosol formulation for the inhalation of beta agonists
Boehringer Ingelheim International 2358353*
- Method of protecting cells
Suomen Punainen Risti 2358354*
- Pharmaceutical compsn of a potent HCV inhibitor for oral administration
Boehringer Ingelheim International 2358355*
- Sustained release systems of ascorbic acid phosphate
Advanced Technologies and Regenerative Medicine 2358356*
- Process for recovering florfenicol from pharmaceutical compsns
Intervet International 2358357*
- Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
Appian Labs 2358358*
- Ceramic honeycomb skin structure
Unifrax 2358359*
- Prolonged release formulations comprising a 2-oxo-1-pyrrolidine derivative
UCB Pharma 2358360*
- Prolonged release formulations comprising a 2-oxo-1-pyrrolidine derivate
UCB Pharma 2358361*
- Stabilised nicotine chewing gum
Watson Laboratories 2358362*
- Polyurethane plaster for the transdermal delivery of active substances, and method for the production thereof
Otto Bock Pur Lifescience 2358363*
- Therapeutics for neurological disorders
The University of Sheffield 2358364*
- Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzimidazole-4-yl-methanone derivatives
Oncotherapy Science 2358365*
- Pharmacokinetically-based dosing regimens of a thrombin receptor antagonist
Schering 2358366*
- Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
Boehringer Ingelheim International 2358367*
- Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
Boehringer Ingelheim International 2358368*
- Process for the preparation of substantially optically pure repaglinide and precursors thereof
KRKA Tovarna Zdravil 2358369*
- Treatment of proteinopathies using a farnesyl transferase inhibitor
Link Medicine 2358370*
- P2X3, receptor antagonists for treatment of pain
Merck Sharp & Dohme 2358371*
- MicroRNA-mediated regulation of UBC9 expression in cancer cells
The Board of Trustees of Southern Illinois University 2358372*
- Injectable polydeoxyribonucleotide compsn for the treatment of osteoarticular diseases
Medevice 2358373*
- Improved dissolution stability of calcium carbonate tablets
Nycomed Pharma 2358374*
- Isolated renal cells and uses thereof
Tengion 2358375*
- Early treatment and prevention of increased muscle tonicity
Allergan 2358376*
- Method for treating Parkinson’s disease using filamentous bacteriophage
Ramot at Tel Aviv University 2358377*
- Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
Laila Pharmaceuticals 2358378*
- Biodefences using triazole-containing macrolides
Cempra Pharmaceuticals 2358379*
- Synthetic mimics of host defence and uses thereof
Polymedix 2358380*
- Compsns for potentiating apoptosis signals in tumour cells
Université Bordeaux Segalen; Institut Bergonié 2358381*
- Novel uses of VEGFxxxB
The University of Bristol 2358382*
- HIV/SIV vaccines for the generation of mucosal and systemic immunity
University of Miami 2358383*
- Agents and treatment for snoring and respiratory effort related arousals in sleep
Cormans, Philip 2358385*
- Optimised influenza vaccines
Statens Serum Institut 2358386*
- Vaccine formulations and uses thereof
Baxter International; Baxter Healthcare 2358387*
- Pharmaceutical product for updosing of allergy vaccine
ALK-Abelló 2358388*